• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Echocardiographic changes in heart-healthy diabetics

Echocardiographic changes in heart-healthy diabetics

Martin Hülsmann (ORCID: 0000-0001-7944-7363)
  • Grant DOI 10.55776/KLI700
  • Funding program Clinical Research
  • Status ended
  • Start May 1, 2018
  • End October 31, 2023
  • Funding amount € 396,627
  • Project website

Disciplines

Clinical Medicine (100%)

Keywords

    Diabetes, Echocardiography, Primery Prevention, NT-proBNP, Cardiac Disease

Abstract

Diabetes mellitus is a disease that affects the way in which the body reacts to sugar that is digested. Type II diabetes usually develops over many years and is believed to be caused by a diet rich in carbohydrates. In developed countries, almost one in every ten people is suffering from diabetes and this number is predicted to increase in the coming decades. At the same time, the treatment of diabetes has improved so much that patients with diabetes commonly reach their 70s and 80s. Patients with diabetes are at a greater risk to also develop diseases that affect the heart and the blood vessels during their life. While this observation was made some thirty years ago, the exact mechanisms by which a high blood glucose leads to cardiac disease is still not fully understood. We believe however that it is a slow process and that it takes many years for a single patient with diabetes to go from a healthy heart to a heart disease such as heart failure. We think that along this way, there are some signs that could help us to identify patients that are at a higher risk than others, even before any symptoms are noticed by the patient or a medical professional. The first of this signs is when the level of a certain hormone called NT-proBNP is elevated in the blood. Patients can feel healthy and normal and even an ultra-sound image of the heart could look perfectly normal because the changes are probably too small. The second sign is when the ultrasound image shows evidence of a disease but the patient still feels fine. This is problematic because patients that feel fine usually dont have these images taken. The third and most obvious is when patients feel unwell and show symptoms of a disease. At this point, patients will be treated for their new disease, often for the rest of their lives. Unfortunately, there is a large blind spot in the phase before patients show symptoms because without them, images and blood tests are not often done. The Medical University of Vienna has started a large scientific study to improve the treatment of patients with diabetes. It will include more than 2000 patients across the globe and will answer the question whether it is useful to treat patients with diabetes that show no signs of a disease of the heart or vessels with certain drugs. As part of this study, we want to collect high-quality ultrasound images of the heart of 600 patients with diabetes. These images will be taken when a patient enters the study and then after two years. We think that this high number of patients will give us the chance to observe patients at many different points of the process to develop a heart disease and also see how these signs change over two years. We want to specifically look at how the heart performs in pumping blood into the circulation and how good it relaxes after pumping. We will use very sensitive tools and measurements to detect even small abnormalities and also study how these abnormalities change over time. This will give us the unique opportunity to observe how patients with diabetes transition from a healthy heart to a heart disease and we hope that we can better identify the group of patients in which we should be especially careful. This could lead to a more personalized treatment and improve the life expectancy and quality of life for many patients. This study will be done at the Medical University of Vienna in cooperation with the Imperial College London.

Research institution(s)
  • Medizinische Universität Wien - 100%
International project participants
  • Richard Troughton, University of Otago - Australia
  • Hans-Peter Brunner - Larocca, Maastricht University Hospital - Netherlands
  • Petros Nihoyannopoulos, Imperial College London

Research Output

  • 137 Citations
  • 14 Publications
Publications
  • 2020
    Title Performance of NT-proBNP as a single biomarker in comparison to SCORE and the recommended ESC/EASD cardiovascular risk stratification model for risk prediction in type 2 diabetes mellitus
    DOI 10.21203/rs.3.rs-58028/v1
    Type Preprint
    Author Prausmüller S
  • 2020
    Title Performance of the recommended ESC/EASD cardiovascular risk stratification model and SCORE in comparison to NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    DOI 10.21203/rs.3.rs-58028/v2
    Type Preprint
    Author Prausmüller S
  • 2020
    Title Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
    DOI 10.1161/jaha.119.015071
    Type Journal Article
    Author Prausmüller S
    Journal Journal of the American Heart Association
    Link Publication
  • 2021
    Title Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failure
    DOI 10.1002/ehf2.13278
    Type Journal Article
    Author Arfsten H
    Journal ESC Heart Failure
    Pages 2016-2024
    Link Publication
  • 2021
    Title Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    DOI 10.21203/rs.3.rs-58028/v3
    Type Preprint
    Author Prausmüller S
    Link Publication
  • 2021
    Title Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    DOI 10.1186/s12933-021-01221-w
    Type Journal Article
    Author Prausmüller S
    Journal Cardiovascular Diabetology
    Pages 34
    Link Publication
  • 2023
    Title CILP-1 Is a Biomarker for Backward Failure and Right Ventricular Dysfunction in HFrEF.
    DOI 10.3390/cells12242832
    Type Journal Article
    Author Prausmüller S
    Journal Cells
  • 2022
    Title Neutrophil Activation/Maturation Markers in Chronic Heart Failure with Reduced Ejection Fraction
    DOI 10.3390/diagnostics12020444
    Type Journal Article
    Author Prausmüller S
    Journal Diagnostics
    Pages 444
    Link Publication
  • 2022
    Title Guideline directed medical therapy and reduction of secondary mitral regurgitation
    DOI 10.1093/ehjci/jeac068
    Type Journal Article
    Author Spinka G
    Journal European Heart Journal - Cardiovascular Imaging
    Pages 755-764
  • 2022
    Title Malnutrition outweighs the effect of the obesity paradox
    DOI 10.1002/jcsm.12980
    Type Journal Article
    Author Prausmüller S
    Journal Journal of Cachexia, Sarcopenia and Muscle
    Pages 1477-1486
    Link Publication
  • 2021
    Title Additional file 1 of Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    DOI 10.6084/m9.figshare.13698344.v1
    Type Other
    Author Resl M
    Link Publication
  • 2021
    Title Additional file 1 of Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    DOI 10.6084/m9.figshare.13698344
    Type Other
    Author Resl M
    Link Publication
  • 2021
    Title Relevance of Neutrophil Neprilysin in Heart Failure
    DOI 10.3390/cells10112922
    Type Journal Article
    Author Prausmüller S
    Journal Cells
    Pages 2922
    Link Publication
  • 2021
    Title Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer
    DOI 10.3389/fcvm.2021.725903
    Type Journal Article
    Author Arfsten H
    Journal Frontiers in Cardiovascular Medicine
    Pages 725903
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF